These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 8065037
21. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease]. Chavarría Olarte ME, González Gleason A, Lara González AL, Sojo Aranda I, García Paleta Y, Vital Reyes VS, Reyes Fuentes A. Ginecol Obstet Mex; 2000 Sep; 68():385-93. PubMed ID: 11080945 [Abstract] [Full Text] [Related]
22. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study]. Ye X, Feng Y, Jin PP, Zhou XH, Ding QL, Wang XF. Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812 [Abstract] [Full Text] [Related]
23. Heterogeneity of the "classical" antithrombin III deficiency. Sas G, Petö I, Bánhegyi D, Blaskó G, Domján G. Thromb Haemost; 1980 Jun 18; 43(2):133-6. PubMed ID: 7455972 [Abstract] [Full Text] [Related]
24. [Blood coagulation parameters in patients with lichen planus]. Wankiewicz A, Iwan-Zietek I, Rość D. Pol Merkur Lekarski; 2004 Jul 18; 17(97):55-7. PubMed ID: 15559612 [Abstract] [Full Text] [Related]
25. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study. Naumnik B, Pawlak K, Myśliwiec M. Thromb Res; 2009 Feb 18; 123(4):631-6. PubMed ID: 18234290 [Abstract] [Full Text] [Related]
26. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. Avidan MS, Levy JH, van Aken H, Feneck RO, Latimer RD, Ott E, Martin E, Birnbaum DE, Bonfiglio LJ, Kajdasz DK, Despotis GJ. J Thorac Cardiovasc Surg; 2005 Jul 18; 130(1):107-13. PubMed ID: 15999048 [Abstract] [Full Text] [Related]
27. Comparative behaviour of antithrombin III antigen and antithrombin III activity in cardiovascular patients. Scrobohaci ML, Făgărăşanu D, Ionescu D, Mihăilă D, Alexandrescu M, Zătreanu I, Orha I. Med Interne; 1983 Jul 18; 21(4):285-8. PubMed ID: 6658342 [Abstract] [Full Text] [Related]
30. Protein C and antithrombin III in children with acute leukemia. Atlihan F, Karakaş Z, Batun S. Turk J Pediatr; 1993 Jul 18; 35(1):45-51. PubMed ID: 8236517 [Abstract] [Full Text] [Related]
36. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium. Khoo SK, Coglan MJ, Wright GR, DeVoss KN, Battistutta D. Med J Aust; 1998 Mar 02; 168(5):216-20. PubMed ID: 9539899 [Abstract] [Full Text] [Related]
37. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study. Aibiki M, Fukuoka N, Nishiyama T, Maekawa S, Shirakawa Y. Shock; 2007 Aug 02; 28(2):141-7. PubMed ID: 17515857 [Abstract] [Full Text] [Related]
38. [Dynamic investigation of antithrombin III in the plasma of patients with acute myocardial infarction]. Zhu JZ, Chen SL, Cui ZC. Zhonghua Nei Ke Za Zhi; 1991 Dec 02; 30(12):746-8, 789. PubMed ID: 1815877 [Abstract] [Full Text] [Related]